Details

DSEN Abstract: Dipeptidyl peptidase-4 (DPP-4) inhibitors were superior to placebo but not statistically different than intermediate-acting insulin in adults with type 2 diabetes: Results of a network meta-analysis - CIHR

Metadata and links for an archived snapshot.

Source
Canadian Institutes of Health Research
Date
Feb 4, 2026 · edition #8
Timestamp
2026-02-04T10:22:45.778Z
Language
en
ID
1315403
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots

Archived page preview